THIOGENESIS THERAPEUTICS COR (TTI.CA) Stock Income Statement
TSX-V:TTI • CA88410L1022
Current stock price
0.44 CAD
-0.04 (-8.33%)
Last:
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 6.98M | 3.58M | 5.21M | 2.01M | N/A | |||
| Research and Development | 5.28M | 2.22M | 4.16M | 1.08M | N/A | |||
| Selling, General, and Administrative Expenses | 1.70M | 1.36M | 1.04M | 933.10K | N/A | |||
| Operating Income | -6.98M | -3.58M | -5.21M | -2.01M | 0.00 | |||
| Interest Income/Expense | 159.50K | 433.50K | 143.00K | 63.50K | N/A | |||
| Other Income/Expense | N/A | N/A | 0.00 | 34.10K | N/A | |||
| Non Recurring Items | N/A | N/A | 0.00 | -2.01M | N/A | |||
| Income Before Taxes | -6.82M | -3.15M | -5.06M | -3.92M | N/A | |||
| Net Income | -6.82M | -3.15M | -5.06M | -3.92M | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.14 | -0.07 | -0.13 | -0.16 | N/A | |||
| Statistics | ||||||||
All data in CAD